Format
Sort by

Send to

Choose Destination

Search results

Items: 7

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

2.

Development of a Multisystemic Parent Management Training Intervention for Incarcerated Parents, Their Children and Families.

Eddy JM, Martinez CR, Schiffmann T, Newton R, Olin L, Leve L, Foney DM, Shortt JW.

Clin Psychol (New York). 2008 Nov 1;12(3):86-98.

3.

From descartes to desipramine: psychopharmacology and the self.

Gold I, Olin L.

Transcult Psychiatry. 2009 Mar;46(1):38-59. doi: 10.1177/1363461509102286.

PMID:
19293279
4.

Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Mark KE, Wald A, Magaret AS, Selke S, Olin L, Huang ML, Corey L.

J Infect Dis. 2008 Oct 15;198(8):1141-9. doi: 10.1086/591913.

5.

Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.

Collier AC, Tierney C, Downey GF, Eshleman SH, Kashuba A, Klingman K, Vergis EN, Pakes GE, Rooney JF, Rinehart A, Mellors JW; AIDS Clinical Trials Group Protocol A5143 Team.

HIV Clin Trials. 2008 Mar-Apr;9(2):91-102. doi: 10.1310/hct0902-91.

PMID:
18474494
6.
7.

Method for determining slow component velocity of nystagmus waveforms.

Miles RD, Rea CB, Konrad HR, Olin LB.

Biomed Sci Instrum. 1986;22:25-8. No abstract available.

PMID:
3754775
Items per page

Supplemental Content

Loading ...
Write to the Help Desk